Aluminum Hydroxide

glutamate decarboxylase 1 ; Homo sapiens







5 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 32754804 Efficacy of GAD-alum immunotherapy associated with HLA-DR3-DQ2 in recently diagnosed type 1 diabetes. 2020 Oct 1
2 23600827 Regulatory T cell phenotype and function 4 years after GAD-alum treatment in children with type 1 diabetes. 2013 Jun 1
3 22587593 Decreased GAD(65)-specific Th1/Tc1 phenotype in children with Type 1 diabetes treated with GAD-alum. 2012 Oct 2
4 21714999 Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial. 2011 Jul 23 2
5 22174945 Long-lasting immune responses 4 years after GAD-alum treatment in children with type 1 diabetes. 2011 3